After-Hours Earnings Report for July 13, 2012 : PDLI

Comment

Shutterstock photo

The following companies are expected to report earnings after hours on 07/13/2012. Visit our Earnings Calendar for a full list of expected earnings releases.

PDL BioPharma, Inc. ( PDLI ) is reporting for the quarter ending June 30, 2012. The biomedical (gene) company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.46. This value represents a 17.95% increase compared to the same quarter last year. PDLI missed the consensus earnings per share in the 2nd calendar quarter by -2.5%. The "days to cover" for this stock exceeds 11 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for PDLI is 4.75 vs. an industry ratio of 16.80.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , Earnings


More from NASDAQ.com News

Subscribe






NASDAQ.com News
Contributor:

NASDAQ.com News

Market News
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com